We are live on !
Find out more
Baird Portfolio holdings
AUM
$9.8B
Turnover
14.34%
1-Year Est. Return
11.39%
This Fund
S&P 500
This Quarter Est. Return
+2.57%
1 Year Est. Return
+11.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.8B
AUM Growth
+$385M
(+4.1%)
Cap. Flow
+$249M
Cap. Flow % of AUM
Cap. Flow %
2.54%
Top 10 Holdings %
Top 10 Hldgs %
13.83%
Holding
1,388
New
121
Increased
618
Reduced
511
Closed
78
Avg Time Held
1.2
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$65.4M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$63.5M |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
+$44.4M |
| 4 |
State Street SPDR EURO STOXX 50 ETF
FEZ
|
+$42.1M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$39.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HSP
HOSPIRA INC
HSP
|
+$54.3M |
| 2 |
PVH
PVH
|
+$43M |
| 3 |
Walmart Inc
WMT
|
+$33M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$30.3M |
| 5 |
Cardinal Health
CAH
|
+$28.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 21.36% |
| 2 | Technology | 13.6% |
| 3 | Industrials | 12.32% |
| 4 | Healthcare | 12.1% |
| 5 | Consumer Discretionary | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Novo Nordisk
NVO
$173B
| $10.9M | 0.11% |
408,928
-195,148
| -32% | -$4.49M |
2013 Q2
7 quarters
|
|
|
BCR
202
DELISTED
CR Bard Inc.
BCR
| $10.6M | 0.11% |
63,113
+2,165
| +4% | +$371K |
2013 Q2
7 quarters
|
|
203
Cognizant
CTSH
$31.2B
| $10.5M | 0.11% |
168,788
+9,101
| +6% | +$537K |
2013 Q2
7 quarters
|
|
204
CME Group
CME
$107B
| $10.4M | 0.11% |
109,694
-3,307
| -3% | -$306K |
2013 Q2
7 quarters
|
|
205
Vanguard Real Estate ETF
VNQ
$36.9B
| $10.3M | 0.11% |
122,295
-2,300
| -2% | -$195K |
2013 Q2
7 quarters
|
|
206
Berkshire Hathaway Class A
BRK.A
$1.16T
| $10.2M | 0.1% |
47
-1
| -2% | -$221K |
2013 Q2
7 quarters
|
|
207
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.62B
| $10.2M | 0.1% |
155,382
+4,066
| +3% | +$261K |
2013 Q2
7 quarters
|
|
|
ABB
208
DELISTED
ABB Ltd
ABB
| $10.2M | 0.1% |
480,143
-158,380
| -25% | -$3.26M |
2013 Q2
7 quarters
|
|
209
iShares S&P Small-Cap 600 Value ETF
IJS
$7.57B
| $10.1M | 0.1% |
170,220
+2,716
| +2% | +$158K |
2013 Q2
7 quarters
|
|
210
Vanguard Morningstar Total Stock Market ETF
VTI
$697B
| $10M | 0.1% |
93,413
+12,761
| +16% | +$1.36M |
2013 Q2
7 quarters
|
|
211
iShares Core US Aggregate Bond ETF
AGG
$138B
| $10M | 0.1% |
89,425
+28,832
| +48% | +$3.2M |
2013 Q2
7 quarters
|
|
212
Medtronic
MDT
$120B
| $9.8M | 0.1% |
126,212
+52,967
| +72% | +$4.01M |
2013 Q2
7 quarters
|
|
213
iShares US Real Estate ETF
IYR
$4.09B
| $9.8M | 0.1% |
123,473
+3,886
| +3% | +$311K |
2013 Q2
7 quarters
|
|
214
iShares 1-3 Year Treasury Bond ETF
SHY
$27B
| $9.7M | 0.1% |
114,539
+7,382
| +7% | +$625K |
2013 Q2
7 quarters
|
|
215
Microchip Technology
MCHP
$41.2B
| $9.6M | 0.1% |
393,716
-6,100
| -2% | -$147K |
2013 Q2
7 quarters
|
|
216
Lowe's Companies
LOW
$110B
| $9.6M | 0.1% |
129,271
+211
| +0.2% | +$15.1K |
2013 Q2
7 quarters
|
|
217
Teva Pharmaceutical Industries Limited
TEVA
$47.7B
| $9.49M | 0.1% |
152,302
-485,554
| -76% | -$28.2M |
2013 Q2
7 quarters
|
|
218
NXP Semiconductors
NXPI
$60.3B
| $9.44M | 0.1% |
94,040
+3,219
| +4% | +$284K |
2013 Q2
7 quarters
|
|
219
Blackrock
BLK
$176B
| $9.4M | 0.1% |
25,690
-8
| -0% | -$2.9K |
2013 Q2
7 quarters
|
|
220
DELISTED
Nordstrom
JWN
| $9.37M | 0.1% |
116,709
-806
| -0.7% | -$63.8K |
2014 Q4
1 quarter
|
|
221
Baxter International
BAX
$12.7B
| $9.3M | 0.1% |
250,074
-552,431
| -69% | -$20.9M |
2013 Q2
7 quarters
|
|
222
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.18B
| $9.18M | 0.09% |
323,152
+3,485
| +1% | +$98.8K |
2013 Q2
7 quarters
|
|
223
Eaton
ETN
$152B
| $9.14M | 0.09% |
134,481
+5,235
| +4% | +$356K |
2013 Q2
7 quarters
|
|
|
AGN
224
DELISTED
Allergan plc
AGN
| $9.08M | 0.09% |
30,517
+9,353
| +44% | +$2.67M |
2013 Q2
7 quarters
|
|
225
State Street Utilities Select Sector SPDR ETF
XLU
$24.6B
| $8.98M | 0.09% |
404,374
-158,152
| -28% | -$3.65M |
2013 Q2
7 quarters
|
|
Similar funds
GIM
Baird's Q1 2015 Portfolio in Review
As of Q1 2015, Baird held 1,388 positions worth $9.8B, up 4.1% from $9.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Baird's Q1 2015 filing shows 121 new, 618 increased, 511 reduced and 78 closed positions. Its largest new stake was Hasbro: 657,109 shares worth $41.6M. The largest sale was HOSPIRA INC, an estimated $54.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.
- Baird's largest Q1 2015 buy was Hasbro: 657,109 shares worth $41.6M.
- Baird added most to AbbVie in Q1 2015, an estimated $65.4M increase.
- Baird's biggest Q1 2015 reduction was HOSPIRA INC, cutting an estimated $54.3M.
- Baird fully exited PVH in Q1 2015, selling an estimated $43M.
- Baird's ten largest holdings make up 14% of its $9.8B portfolio in Q1 2015.
- Baird opened 121 new positions and closed 78 in Q1 2015.
- Baird's portfolio value rose 4.1% quarter-over-quarter to $9.8B.
Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.